Ga verder naar de inhoud
O:28:"craft\elements\db\AssetQuery":97:{s:27:"�yii\base\Component�_events";a:0:{}s:35:"�yii\base\Component�_eventWildcards";a:0:{}s:30:"�yii\base\Component�_behaviors";a:1:{s:12:"customFields";O:35:"craft\behaviors\CustomFieldBehavior":73:{s:5:"owner";r:1;s:34:"�yii\base\Behavior�_attachedEvents";a:0:{}s:10:"hasMethods";b:1;s:16:"canSetProperties";b:1;s:4:"mail";N;s:13:"overviewImage";N;s:7:"twitter";N;s:19:"overviewDescription";N;s:12:"imageCaption";N;s:13:"overviewTitle";N;s:4:"hero";N;s:14:"contentBuilder";N;s:7:"youtube";N;s:3:"seo";N;s:9:"instagram";N;s:5:"image";N;s:5:"intro";N;s:8:"linkedin";N;s:8:"facebook";N;s:15:"backgroundColor";N;s:5:"video";N;s:7:"entries";N;s:10:"blockTitle";N;s:12:"titleColumn1";N;s:10:"ctaColumn2";N;s:11:"textColumn2";N;s:11:"textColumn1";N;s:10:"ctaColumn1";N;s:12:"titleColumn2";N;s:4:"text";N;s:6:"writer";N;s:3:"cta";N;s:8:"position";N;s:6:"linkit";N;s:8:"devStage";N;s:15:"therapeuticArea";N;s:7:"disease";N;s:6:"timing";N;s:7:"website";N;s:8:"partners";N;s:9:"partnered";N;s:6:"target";N;s:10:"percentage";N;s:10:"detailPage";N;s:7:"address";N;s:4:"city";N;s:7:"country";N;s:12:"addressLine2";N;s:12:"addressLine1";N;s:5:"phone";N;s:6:"people";N;s:8:"heroHome";N;s:10:"aboutBlock";N;s:6:"blocks";N;s:13:"projectsBlock";N;s:8:"projects";N;s:11:"impactBlock";N;s:6:"number";N;s:8:"ctaBlock";N;s:4:"ctas";N;s:17:"depublicationDate";N;s:14:"introTranslate";N;s:28:"overviewDescriptionTranslate";N;s:22:"overviewImageTranslate";N;s:22:"overviewTitleTranslate";N;s:23:"contentBuilderTranslate";N;s:6:"linkIt";N;s:13:"fallbackImage";N;s:5:"color";N;s:9:"areaColor";N;s:9:"formIntro";N;s:22:"primaryTherapeuticArea";N;s:55:"�craft\behaviors\CustomFieldBehavior�_customFieldValues";a:0:{}}}s:6:"select";a:1:{s:2:"**";s:2:"**";}s:12:"selectOption";N;s:8:"distinct";b:0;s:4:"from";N;s:7:"groupBy";N;s:4:"join";a:1:{i:0;a:3:{i:0;s:10:"INNER JOIN";i:1;a:1:{s:9:"relations";s:14:"{{%relations}}";}i:2;a:4:{i:0;s:3:"and";i:1;s:40:"[[relations.targetId]] = [[elements.id]]";i:2;a:2:{s:18:"relations.sourceId";i:394;s:17:"relations.fieldId";i:111;}i:3;a:3:{i:0;s:2:"or";i:1;a:1:{s:22:"relations.sourceSiteId";N;}i:2;a:1:{s:22:"relations.sourceSiteId";i:1;}}}}}s:6:"having";N;s:5:"union";N;s:11:"withQueries";N;s:6:"params";a:0:{}s:18:"queryCacheDuration";N;s:20:"queryCacheDependency";N;s:5:"where";N;s:5:"limit";i:1;s:6:"offset";N;s:7:"orderBy";a:1:{s:19:"relations.sortOrder";i:4;}s:7:"indexBy";N;s:16:"emulateExecution";b:0;s:11:"elementType";s:20:"craft\elements\Asset";s:5:"query";N;s:8:"subQuery";N;s:12:"contentTable";s:12:"{{%content}}";s:12:"customFields";N;s:9:"inReverse";b:0;s:7:"asArray";b:0;s:18:"ignorePlaceholders";b:0;s:6:"drafts";b:0;s:17:"provisionalDrafts";b:0;s:7:"draftId";N;s:7:"draftOf";N;s:12:"draftCreator";N;s:15:"savedDraftsOnly";b:0;s:9:"revisions";b:0;s:10:"revisionId";N;s:10:"revisionOf";N;s:15:"revisionCreator";N;s:2:"id";N;s:3:"uid";N;s:14:"siteSettingsId";N;s:10:"fixedOrder";b:0;s:6:"status";a:1:{i:0;s:7:"enabled";}s:8:"archived";b:0;s:7:"trashed";b:0;s:11:"dateCreated";N;s:11:"dateUpdated";N;s:6:"siteId";i:1;s:6:"unique";b:0;s:11:"preferSites";N;s:6:"leaves";b:0;s:9:"relatedTo";N;s:5:"title";N;s:4:"slug";N;s:3:"uri";N;s:6:"search";N;s:3:"ref";N;s:4:"with";N;s:16:"withCustomFields";b:1;s:13:"withStructure";N;s:11:"structureId";N;s:5:"level";N;s:14:"hasDescendants";N;s:10:"ancestorOf";N;s:12:"ancestorDist";N;s:12:"descendantOf";N;s:14:"descendantDist";N;s:9:"siblingOf";N;s:13:"prevSiblingOf";N;s:13:"nextSiblingOf";N;s:16:"positionedBefore";N;s:15:"positionedAfter";N;s:17:"�*�defaultOrderBy";a:2:{s:20:"elements.dateCreated";i:3;s:11:"elements.id";i:3;}s:53:"�craft\elements\db\ElementQuery�_placeholderCondition";N;s:51:"�craft\elements\db\ElementQuery�_placeholderSiteIds";N;s:39:"�craft\elements\db\ElementQuery�_result";N;s:47:"�craft\elements\db\ElementQuery�_resultCriteria";N;s:46:"�craft\elements\db\ElementQuery�_searchResults";N;s:42:"�craft\elements\db\ElementQuery�_cacheTags";N;s:42:"�craft\elements\db\ElementQuery�_columnMap";a:0:{}s:51:"�craft\elements\db\ElementQuery�_joinedElementTable";b:0;s:8:"editable";N;s:7:"savable";N;s:8:"volumeId";N;s:8:"folderId";N;s:10:"uploaderId";N;s:8:"filename";N;s:4:"kind";N;s:6:"hasAlt";b:1;s:5:"width";N;s:6:"height";N;s:4:"size";N;s:12:"dateModified";N;s:17:"includeSubfolders";b:0;s:10:"folderPath";N;s:14:"withTransforms";N;}

Turning promising science into the medicines of tomorrow

CD3 is an investment fund and drug discovery center focusing on the discovery of new drugs based on innovative science from our partners. We bridge the gap between innovative biomedical research emerging from academic institutes or biotechs and the pharmaceutical industry, and create value for all stakeholders.

CD3’s activities and capabilities

DSCF8318

Expertise in drug discovery

We have state-of-the-art drug discovery expertise and capabilities at hand

DSCF8292

Co-creating new drugs

We collaborate with academic researchers and biotech/pharma partners on drug discovery projects

Invest impact klein

Investing with impact

We invest in drug discovery spin-offs and biotechs

Latest research news

Enedra

CD3 announces investment in Enedra Therapeutics to advance drug discovery programmes from its proprietary CASPAROV platform for difficult to treat cancers

Enedra Therapeutics has secured venture financing and non-dilutive funding through UKRI’s Innovate UK Future Economy Investor Partnerships programme to support the development of next-generation precision therapies for advanced, genetically heterogeneous cancers.

Projects in the spotlight

Picture1
Infectious diseases
Image
Partnered project
Disease: Dengue virus
Yap TAZ TEAD inhibitors klein
Cancer
Image
Partnered project
Disease: Mesothelioma, lung cancer ao
Rsv klein
Infectious diseases
Image
Partnered project
Disease: RSV

Investing with impact

35+

Drug discovery projects initiated

15+

Partnerships with pharma or biotech companies

50+

Million Euro invested

Want to co-create with us?

We are looking forward to collaborating with you to discover new medicines that address some of the most serious medical needs of our time.